Statistics for Survival efficacy of the PEGylated G-CSFs Maxy-G34 and neulasta in a mouse model of lethal H-ARS, and residual bone marrow damage in treated survivors
Total visits
| views | |
|---|---|
| Survival efficacy of the PEGylated G-CSFs Maxy-G34 and neulasta in a mouse model of lethal H-ARS, and residual bone marrow damage in treated survivors | 326 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| nihms515628.pdf | 300 |
| java.util.UUID:8fada5c1-d383-4ade-a4d5-0bd7e21a9ff8 | 62 |
| java.util.UUID:48294680-69ff-466e-9036-6bfa3ad1c246 | 29 |
| java.util.UUID:2944614b-9ec4-403c-a502-a4b22e7dc690 | 7 |
Top country views
| views | |
|---|---|
| United States | 237 |
| Germany | 19 |
| China | 8 |
| Ukraine | 7 |
| Russia | 4 |
| United Kingdom | 3 |
| Canada | 2 |
| Belgium | 1 |
| France | 1 |
| India | 1 |
| South Korea | 1 |
| Lebanon | 1 |
| Malaysia | 1 |
| Pakistan | 1 |
| Poland | 1 |
| Sweden | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 89 |
| Fairfield | 32 |
| Ann Arbor | 21 |
| Kiez | 14 |
| Houston | 13 |
| Cambridge | 11 |
| Jacksonville | 7 |
| White Plains | 7 |
| Falls Church | 6 |
| Kiev | 6 |
| Shenzhen | 6 |
| Lake Mary | 5 |
| Indianapolis | 3 |
| Munich | 3 |
| Philadelphia | 3 |
| Saint Petersburg | 3 |
| Concord | 2 |
| Gunzenhausen | 2 |
| San Francisco | 2 |
| Seattle | 2 |
| Toronto | 2 |
| Washington | 2 |
| Alexandria | 1 |
| Augusta | 1 |
| Baltimore | 1 |
| Beirut | 1 |
| Brooklyn | 1 |
| Buffalo | 1 |
| Fuzhou | 1 |
| Islamabad | 1 |
| Kaluzhskaya | 1 |
| Katowice | 1 |
| Lake Forest | 1 |
| Mountain View | 1 |
| Norwalk | 1 |
| Overland Park | 1 |
| Richmond | 1 |
| Roubaix | 1 |
| Scottsdale | 1 |
| Seoul | 1 |
| Seremban | 1 |
| Stockholm | 1 |
| Thiruvananthapuram | 1 |
| Vladimir | 1 |
| Warrington | 1 |
| Zaventem | 1 |